Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets.

Myasthenia gravis (MG) is a well-recognised disorder of neuromuscular transmission that can be diagnosed by the presence of antibodies to the acetylcholine receptor (AChR). However, some patients (about 15%) with generalised MG do not have detectable AChR antibodies. There is some evidence, however,...

詳細記述

書誌詳細
主要な著者: Vincent, A, Bowen, J, Newsom-Davis, J, McConville, J
フォーマット: Journal article
言語:English
出版事項: 2003

類似資料